GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (HKSE:01099) » Definitions » Days Payable

Sinopharm Group Co (HKSE:01099) Days Payable : 104.72 (As of Jun. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sinopharm Group Co Days Payable?

Sinopharm Group Co's average Accounts Payable for the six months ended in Jun. 2024 was HK$168,511 Mil. Sinopharm Group Co's Cost of Goods Sold for the six months ended in Jun. 2024 was HK$293,663 Mil. Hence, Sinopharm Group Co's Days Payable for the six months ended in Jun. 2024 was 104.72.

The historical rank and industry rank for Sinopharm Group Co's Days Payable or its related term are showing as below:

HKSE:01099' s Days Payable Range Over the Past 10 Years
Min: 90.95   Med: 98.74   Max: 104.97
Current: 104.94

During the past 13 years, Sinopharm Group Co's highest Days Payable was 104.97. The lowest was 90.95. And the median was 98.74.

HKSE:01099's Days Payable is ranked better than
66.04% of 106 companies
in the Medical Distribution industry
Industry Median: 76.035 vs HKSE:01099: 104.94

Sinopharm Group Co's Days Payable increased from Jun. 2023 (99.99) to Jun. 2024 (104.72). It may suggest that Sinopharm Group Co delayed paying its suppliers.


Sinopharm Group Co Days Payable Historical Data

The historical data trend for Sinopharm Group Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Group Co Days Payable Chart

Sinopharm Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 93.41 96.04 94.07 104.97 100.70

Sinopharm Group Co Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 102.76 97.28 99.99 105.09 104.72

Competitive Comparison of Sinopharm Group Co's Days Payable

For the Medical Distribution subindustry, Sinopharm Group Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopharm Group Co's Days Payable Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Sinopharm Group Co's Days Payable falls into.



Sinopharm Group Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Sinopharm Group Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (161495.587 + 169259.473) / 2 ) / 599454.145*365
=165377.53 / 599454.145*365
=100.70

Sinopharm Group Co's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

Days Payable (Q: Jun. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Jun. 2024 )) / count ) / Cost of Goods Sold (Q: Jun. 2024 )*Days in Period
=( (169259.473 + 167762.987) / 2 ) / 293663.315*365 / 2
=168511.23 / 293663.315*365 / 2
=104.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinopharm Group Co Days Payable Related Terms

Thank you for viewing the detailed overview of Sinopharm Group Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Group Co Business Description

Traded in Other Exchanges
Address
No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2023. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Lazard Asset Management Llc 2102 Investment manager
Zhong Xin Zheng Quan Yun Fan Dan Yi Zi Chan Guan Li Ji Hua 2501 Other
Zhong Xin Zheng Quan Zi Chan Guan Li You Xian Gong Si 2102 Investment manager
Citic Securities Company Limited 2201 Interest of corporation controlled by you
Citigroup Inc. 2502 Approved lending agent
Fmr Llc 2201 Interest of corporation controlled by you
Blackrock, Inc. 2201 Interest of corporation controlled by you

Sinopharm Group Co Headlines

No Headlines